Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

Two years ago, a researcher who specializes in the safety of breast milk was in the midst of breastfeeding her own child when she experienced a serious bout of postpartum depression. She had a televisit with her doctor, who refused to write her a prescription for antidepressant medications as long as she was still breastfeeding, even though the drugs are considered safe to take during pregnancy and breastfeeding.  “A lot of times, [the] health [of the new mother] isn’t prioritized as much as that of the infant. And that’s something that we really worry about,” says Kaytlin Krutsch, PharmD, a…

Read More

In the last week of September 2021, a group of more than 90 doctors and researchers published a call to action, cautioning against the liberal use of Tylenol (acetaminophen) during pregnancy. The studies suggested that exposure to the drug could increase the risk of a baby having neurodevelopmental, reproductive and urogenital disorders. The authors added, however, that Tylenol has long been considered one of the few safer options to treat pain in pregnancy, since Advil (ibuprofen) and opioids are considered riskier. They pointed out that, in some cases, a woman’s condition (fever and pain, for example) could be worse for…

Read More